Patents by Inventor Zahia Hannas-Djebbara

Zahia Hannas-Djebbara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
    Patent number: 10537632
    Abstract: The present disclosure encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs are formed by the CPV VP2 protein. Further, the disclosure broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: January 21, 2020
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Frederic David, Zahia Hannas-Djebbara, Herve Poulet, Jules Maarten Minke
  • Canine Parvovirus (CPV) Virus-like Particle (VLP) Vaccines and uses thereof
    Publication number: 20190000965
    Abstract: The present disclosure encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs are formed by the CPV VP2 protein. Further, the disclosure broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.
    Type: Application
    Filed: August 22, 2018
    Publication date: January 3, 2019
    Applicant: MERIAL, INC.
    Inventors: Frederic David, Zahia Hannas-Djebbara, Herve Poulet, Jules Maarten Minke
  • Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
    Patent number: 10080798
    Abstract: The present invention encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs provided by the invention are formed by the CPV VP2 protein. Further, the invention broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: September 25, 2018
    Assignee: MERIAL INC.
    Inventors: Frederic David, Zahia Hannas-Djebbara, Herve Poulet, Jules Maarten Minke
  • FMDV recombinant vaccines and uses thereof
    Patent number: 10010605
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: July 3, 2018
    Assignee: Merial, Inc.
    Inventors: Jean-Christophe Audonnet, Zahia Hannas-Djebbara, Teshome Mebatsion, Yu-Wei Chiang, Justin Widener, Frédéric Reynard
  • Canine Parvovirus (CPV) Virus-like Particle (VLP) Vaccines and uses thereof
    Publication number: 20170087244
    Abstract: The present invention encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs provided by the invention are formed by the CPV VP2 protein. Further, the invention broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 30, 2017
    Applicant: MERIAL, INC.
    Inventors: Frederic David, Zahia Hannas-Djebbara, Herve Poulet, Jules Maarten Minke
  • FMDV RECOMBINANT VACCINES AND USES THEREOF
    Publication number: 20160220659
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Application
    Filed: September 23, 2015
    Publication date: August 4, 2016
    Applicant: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Zahia Hannas-Djebbara, Teshome Mebatsion, Yu-Wei Chiang, Justin Widener, Frédéric Reynard